Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis
Figure 1
Systolic (SBP) and diastolic (DBP) blood pressure before start with an aldosterone-receptor antagonist (baseline), at first followup (FU), and at the end of FU in patients with essential hypertension (EH) and primary aldosteronism (PA). Overall trend was tested with one-way ANOVA for repeated measurements ( for all groups, except for DBP in the PA group ()). Indicated significance levels are for differences between groups after adjustment for multiple comparisons (*compared to baseline; #compared to first FU).
